Skip to main content

Better Therapeutics, Inc.

BTTXDelisted May 16, 2024
Industry
Services-Health Services
SEC CIK
0001832415

Better Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Feb 13, 2024; 22 institutions reported holding it in 13F filings for Q4 2023, worth $281.2K in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Better Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
18
+3 vs. Q2 2023
Shares held
2.53M
+1.45M (+134.3%) vs. Q2 2023
Total value
$931.1K
−$234.7K (−20.1%) vs. Q2 2023
New holders
6
5 more added
Sold out
3
2 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BTTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 18 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 20 institutionsQ1 2022: 14 institutionsQ2 2022: 14 institutionsQ3 2022: 16 institutionsQ4 2022: 17 institutionsQ1 2023: 15 institutionsQ2 2023: 15 institutionsQ3 2023: 18 institutionsQ4 2023: 22 institutionsQ1 2024: 3 institutionsQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2023: $931.1K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $16.4MQ1 2022: $7.16MQ2 2022: $2.77MQ3 2022: $3.11MQ4 2022: $1.75MQ1 2023: $1.04MQ2 2023: $1.17MQ3 2023: $931.1KQ4 2023: $281.2KQ1 2024: $1.45KQ2 2024: $37Q3 2024: $0Q4 2024: $0Q1 2025: $1Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BTTX and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$1
Q4 20241$0
Q3 20241$0
Q2 20241$37
Q1 20243$1.45K
Q4 202322$281.2K
Q3 202318$931.1K
Q2 202315$1.17M
Q1 202315$1.04M
Q4 202217$1.75M
Q3 202216$3.11M
Q2 202214$2.77M
Q1 202214$7.16M
Q4 202120$16.4M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Better Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding BTTX in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
MMCAP International Inc. SPC1,583,079$579.4K0.17%+1,583,079New
Vanguard Group Inc499,897$183.0K0.00%+61,418+14.0%Added
Geode Capital Management, LLC106,878$41.2K0.00%−14,846−12.2%Reduced
BlackRock Inc.89,025$32.6K0.00%−1,365−1.5%Reduced
State Street Corp58,600$22.6K0.00%+13,400+29.6%Added
Capital Investment Advisory Services, LLC41,000$15.0K0.00%+41,000New
Millennium Management LLC36,873$14.2K0.00%+36,873New
Citadel Advisors LLC26,166$10.1K0.00%+26,166New
Tower Research Capital LLC (TRC)22,868$8.37K0.00%+18,069+376.5%Added
Group One Trading, L.P.18,698$7.21K0.00%+15,696+522.9%Added
Northern Trust Corp16,703$6.11K0.00%00.0%Unchanged
NWF Advisory Services Inc.15,460$5.66K0.00%+15,460New
Ameriprise Financial Inc15,000$5.49K0.00%00.0%Unchanged
Aspire Private Capital, LLC200$730.00%00.0%Unchanged
Wells Fargo & Company121$440.00%+4+3.4%Added
PSI Advisors, LLC65$240.00%00.0%Unchanged
JPMorgan Chase & Co13$50.00%+13New
Royal Bank of Canada194$00.00%00.0%Unchanged
Farallon Capital Management, L.L.C.0$00.00%−330,619−100.0%Sold out
Renaissance Technologies LLC0$00.00%−13,400−100.0%Sold out
Barclays PLC0$00.00%−232−100.0%Sold out